ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
ACRO BIOMEDICAL CO., LTD.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $1.56M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Acro Biomedical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Acro Biomedical filed with the SEC
FORM 8-K
Event dated Sep 2, 2026, from SEC EDGAR
FORM 8-K
Event dated Jan 4, 2026, from SEC EDGAR
FORM 8-K
Event dated Aug 14, 2025, from SEC EDGAR
FORM 8-K
Event dated Jun 30, 2025, from SEC EDGAR
FORM 8-K
Event dated Aug 7, 2020, from SEC EDGAR
FORM 8-K
Event dated Jan 13, 2020, from SEC EDGAR
FORM 8-K
Event dated Oct 18, 2018, from SEC EDGAR